Research Paper Volume 15, Issue 7 pp 2734—2771
Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
Figure 6. Relationship between TSEN54 expression and prognosis of HCC patients. The relation between TSEN54 expression and (A) OS; (B) PFS; (C) RFS; (D) DSS based on the Kaplan-Meier plotter database. (E) The correlation between TSEN54 expression and the survival of HCC patients based on the TISIDB website. Survival of HCC patients with (F) differential TSEN54 expression; (G) differential TSEN54 expression and grade; (H) differential TSEN54 expression and race.